Evonik Industries AG

Evonik’s Q3 2025 earnings reveal a specialty‑chemicals slump driven by US tariffs, weak EU demand, and China’s real‑estate downturn, highlighting the need for cost discipline and innovation to sustain margins.

Evonik Industries AG, a German specialty-chemical company, has a stable share price and a strong long-term outlook, driven by growth in its Active Pharmaceutical Ingredient and polyamide segments, despite facing challenges from inflation, currency m…

Evonik Industries AG, a German specialty-chemicals manufacturer, faces challenges in its share price, revenue growth, and profitability, but also presents opportunities for growth in emerging markets and through strategic partnerships, requiring inv…

Evonik Industries AG, a German specialty-chemical producer, has experienced a significant decline in its share price over the past year, but its foundational strengths and potential strategic moves into growth markets like 3D printing materials coul…

Evonik Industries AG, a German specialty-chemical producer, has revised its 2025 outlook, lowering its adjusted EBITDA forecast to €1.9 billion due to persistently weak demand and a contraction in key revenue segments.

Evonik Industries, a global leader in specialty chemicals, has seen its share price surge by over 12% in the last month, driven by robust fundamentals, growing demand for its products, and a favorable macroeconomic context, with analysts recommendin…

Evonik Industries AG, a German specialty-chemicals conglomerate, has experienced a sharp price uptick, outpacing the broader German equity market, driven by solid financial fundamentals, regulatory advantages, and a forward-looking innovation pipeli…

Evonik Industries AG, a German specialty-chemical company, has seen its share price decline and market capitalization fall due to the broader German chemical and pharmaceutical sector’s downturn in 2025.

Evonik Industries AG, a German specialty chemicals company, has seen its stock price plummet by nearly 50% due to poor management, lack of diversification, and inadequate response to market shifts, leaving investors with significant losses.

Evonik Industries AG, a German specialty chemicals company, is navigating volatile market conditions, but its long-term prospects remain strong due to growing demand for specialty polymers.